Skip to content
Insider tapeFilings through Fri, Oct 9
Watchlist

Lynn Seely

CEO, President at Lyell Immunopharma, Inc. (LYEL)

Purchase track record

Not enough history. Based on 0 purchases with a full 90 days of price history.

—
Avg. 90-day return—
vs. S&P 500—
Beat the market—
Paper profit on buys$0
Total bought / sold$0 / $353K

Reported trades

Filed Stock Type Shares Price Value Since
Aug 25SEC LYELLyell Immunopharma, Inc. Sell 9,58963,899 held (−13%) $15.54 $149K -44.0%
Aug 11SEC LYELLyell Immunopharma, Inc. Sell 39073,488 held (−1%) $14.34 $6K -39.3%
Jun 15SEC LYELLyell Immunopharma, Inc. Sell 38873,878 held (−1%) $18.91 $7K -53.9%
Feb 12SEC LYELLyell Immunopharma, Inc. Sell 7,45574,266 held (−9%) $23.39 $174K -62.8%
Feb 11SEC LYELLyell Immunopharma, Inc. Sell 43881,721 held (−1%) $23.12 $10K -62.3%
Nov 12SEC LYELLyell Immunopharma, Inc. Sell 41267,159 held (−1%) $16.11 $7K -45.9%